arrow
Back
R

Raymond S. Douglas

University of California System

47H-index
223Paper Count
7.9KCitation Count
Published Papers 63
Publication Date
The Use of Biologics for Thyroid Eye Disease
err2025-06-06
err0
PREAI
errShoaib Ugradar; Emanuil Parunakian; Raymond S. Douglas
errShare
errSave
The Rate of Re-treatment in Patients Treated with Teprotumumab A Multicenter Study of 119 Patients with 1 Year of Follow-up
err2025-01-01
err2
PREAI
errUgradar, Shoaib; Parunakian, Emanuil; Malkhasyan, Emil; Chiou, Carolina A.; Walsh, Hannah L.; Tolentino, Joseph; Wester, Sara T.; Freitag, Suzanne K.; Douglas, Raymond S.
errShare
errSave
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells
err2024-12-11
err0
errOAAI
errLuffy, Maximilian; Ganz, Anna-Lena; Wagner, Stefanie; Wolf, Jan; Ropertz, Julian; Zeidan, Ryan; Kent, Jeffrey D.; Douglas, Raymond S.; Kahaly, George J.
errShare
errSave
Teprotumumab-Related Adverse Events in Thyroid Eye Disease A Multicenter Study
err2024-04-01
err7
PREAI
errShah, Shreya A.; Amarikwa, Linus; Sears, Connie M.; Clauss, Kevin D.; Rajjoub, Raneem D.; Kang, Julia Y.; Tamhankar, Madhura A.; Briceno, Cesar A.; Harrison, Andrew R.; Dosiou, Chrysoula; Cockerham, Kimberly P.; Wester, Sara T.; Douglas, Raymond S.; Kossler, Andrea L.
errShare
errSave
A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease
errTHYROID
IF6.7
err2024-01-01
err9
errOAAI
errDouglas, Raymond S.; Parunakian, Emanuil; Tolentino, Joseph; Malkhasyan, Emil; Geng, June; Sherman, Michele; Ugradar, Shoaib
errShare
errSave
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity
err2023-10-31
err21
errOAAI
errDouglas, Raymond S.; Couch, Steven; Wester, Sara T.; Fowler, Brian T.; Liu, Catherine Y.; Subramanian, Prem S.; Tang, Rosa; Nguyen, Quang T.; Maamari, Robi N.; Ugradar, Shoaib; Hsu, Kate; Karon, Michael; Stan, Marius N.
errShare
errSave
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
err2023-06-30
err21
errOAAI
errKahaly, George J.; Dolman, Peter J.; Wolf, Jan; Giers, Bert C.; Elflein, Heike M.; Jain, Amy P.; Srinivasan, Ashok; Hadjiiski, Lubomir; Jordan, David; Bradley, Elizabeth A.; Stan, Marius N.; Eckstein, Anja; Pitz, Susanne; Vorlaender, Christian; Wester, Sara T.; Nguyen, John; Tucker, Nancy; Sales-Sanz, Marco; Feldon, Steven E.; Nelson, Christine C.; Hardy, Isabelle; Abia-Serrano, Maravillas; Tedeschi, Philip; Janes, Jonathan M.; Xu, Jing; Vue, Peter; Macias, William L.; Douglas, Raymond S.
errShare
errSave
Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED)
err2023-04-25
err2
PREAI
errMoster, Mark; Douglas, Raymond; Cockerham, Kimberly; Turbin, Roger; Nijhawan, Navdeep; Schiffman, Jade; Ugradar, Shoaib; O'Shaughnessy, Denis; Summerfelt, Rochelle; She, Angela; Katz, Barrett
errShare
errSave
Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab
err2023-02-09
err9
PREAI
errUgradar, Shoaib; Zimmerman, Erin; Parunakian, Emanuil; Kang, Julia; Cockerham, Kimberly; Douglas, Raymond S.
errShare
errSave
The Management of Lumps, Bumps, and Contour Irregularities of the Lower Eyelid and Cheek After Poor Outcome Fat Transfer
err2023-02-02
err5
PREAI
errUgradar, Shoaib; Wang, Yao; Patel, Amy; Holds, John B.; Douglas, Raymond; Massry, Guy
errShare
errSave
Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States
err2022-09-01
err15
errOAAI
errWang, Yao; Padnick-Silver, Lissa; Francis-Sedlak, Megan; Holt, Robert J.; Foley, Colleen; Douglas, Raymond S.
errShare
errSave
errShare
errSave
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment
err2022-04-01
err84
errOAAI
errDouglas, Raymond S.; Kahaly, George J.; Ugradar, Shoaib; Elflein, Heike; Ponto, Katharina A.; Fowler, Brian T.; Dailey, Roger; Harris, Gerald J.; Schiffman, Jade; Tang, Rosa; Wester, Sara; Jain, Amy Patel; Marcocci, Claudio; Marino, Michele; Antonelli, Alessandro; Eckstein, Anja; Fuhrer-Sakel, Dagmar; Salvi, Mario; Sile, Saba; Francis-Sedlak, Megan; Holt, Robert J.; Smith, Terry J.
errShare
errSave
Improvement of asymmetric thyroid eye disease with teprotumumab
err2021-02-12
err14
errOAAI
errUgradar, Shoaib; Wang, Yao; Mester, Tunde; Kahaly, George J.; Douglas, Raymond
errShare
errSave
Thyroid eye disease: Redefining its management-A review
err2021-01-22
err18
PREAI
errJain, Amy P.; Jaru-Ampornpan, Pimkwan; Douglas, Raymond S.
errShare
errSave
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease
err2020-11-10
err45
PREAI
errJain, Amy Patel; Gellada, Norman; Ugradar, Shoaib; Kumar, Ada; Kahaly, George; Douglas, Raymond
errShare
errSave
Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
err2020-09-25
err10
errOAAI
errWang, Yao; Sharma, Anu; Padnick-Silver, Lissa; Francis-Sedlak, Megan; Holt, Robert J.; Foley, Colleen; Massry, Guy; Douglas, Raymond S.
errShare
errSave
Dermal Onlay Grafts: A Rescue Procedure for Secondary Inferior Periorbital Hollows
err2020-07-22
err2
PREAI
errWang, Yao; Douglas, Raymond S.; Patel, Amy; Holds, John; Massry, Guy G.
errShare
errSave
Teprotumumab for the Treatment of Active Thyroid Eye Disease
err2020-01-23
err418
errOAAI
errDouglas, R. S.; Kahaly, G. J.; Patel, A.; Sile, S.; Thompson, E. H. Z.; Perdok, R.; Fleming, J. C.; Fowler, B. T.; Marcocci, C.; Marino, M.; Antonelli, A.; Dailey, R.; Harris, G. J.; Eckstein, A.; Schiffman, J.; Tang, R.; Nelson, C.; Salvi, M.; Wester, S.; Sherman, J. W.; Vescio, T.; Holt, R. J.; Smith, T. J.
errShare
errSave
A New Era in the Treatment of Thyroid Eye Disease
err2019-12-01
err46
errOAAI
errPatel, Amy; Yang, Huasheng; Douglas, Raymond S.
errShare
errSave